167 related articles for article (PubMed ID: 3422078)
1. Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta).
Mitjavila MT; Vinci G; Villeval JL; Kieffer N; Henri A; Testa U; Breton-Gorius J; Vainchenker W
J Cell Physiol; 1988 Jan; 134(1):93-100. PubMed ID: 3422078
[TBL] [Abstract][Full Text] [Related]
2. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells.
Ottmann OG; Pelus LM
J Immunol; 1988 Apr; 140(8):2661-5. PubMed ID: 3258618
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of highly purified human platelet beta-thromboglobulin on in vitro human megakaryocyte colony formation.
Abgrall JF; Han ZC; Sensebe L; Le Gall G; Guern G; Renard I; Briere J
Exp Hematol; 1991 Mar; 19(3):202-5. PubMed ID: 1825299
[TBL] [Abstract][Full Text] [Related]
4. Suppression of maturation of megakaryocyte colony forming unit in vitro by a platelet-released glycoprotein.
Dessypris EN; Gleaton JH; Sawyer ST; Armstrong OL
J Cell Physiol; 1987 Mar; 130(3):361-8. PubMed ID: 3558491
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of transforming growth factor-beta 1 on distinct developmental stages of murine megakaryocytopoiesis.
Jackson H; Williams N; Westcott KR; Green R
J Cell Physiol; 1994 Nov; 161(2):312-8. PubMed ID: 7962115
[TBL] [Abstract][Full Text] [Related]
6. Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures: role of TGF beta.
Berthier R; Valiron O; Schweitzer A; Marguerie G
Stem Cells; 1993 Mar; 11(2):120-9. PubMed ID: 7681339
[TBL] [Abstract][Full Text] [Related]
7. [Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action].
Han ZC; Zhang XJ; Xi XD; Lu M; Jiang S; Jiang LZ; Wang XM; Gu GL; Caen JP
Shi Yan Sheng Wu Xue Bao; 1995 Dec; 28(4):415-26. PubMed ID: 8731973
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
9. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
10. New insights into the regulation of human megakaryocytopoiesis.
Hoffman R; Straneva J; Yang HH; Bruno E; Brandt J
Blood Cells; 1987; 13(1-2):75-86. PubMed ID: 3499196
[TBL] [Abstract][Full Text] [Related]
11. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
[TBL] [Abstract][Full Text] [Related]
12. Human bone marrow stromal cell colonies: response to hydrocortisone and dependence on platelet-derived growth factor.
McIntyre AP; Bjornson BH
Exp Hematol; 1986 Oct; 14(9):833-9. PubMed ID: 3019748
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
15. [Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].
Caen JP; Xi X; Aidoudi S; Fournier S; Schlegel N; Bellucci S; Han ZC
Bull Acad Natl Med; 1995 Nov; 179(8):1657-70. PubMed ID: 8717183
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
Espevik T; Figari IS; Ranges GE; Palladino MA
J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680
[TBL] [Abstract][Full Text] [Related]
17. Regulation of colony-stimulating factor 1-dependent macrophage precursor proliferation by type beta transforming growth factor.
Strassmann G; Cole MD; Newman W
J Immunol; 1988 Apr; 140(8):2645-51. PubMed ID: 3258617
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocyte colony growth-supporting activities in human plasma: modification by platelets and platelet membranes.
Yamasaki K; Jamal N; Mann KG; Messner HA
J Cell Physiol; 1987 Nov; 133(2):337-43. PubMed ID: 3500177
[TBL] [Abstract][Full Text] [Related]
20. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
